178 related articles for article (PubMed ID: 27998070)
1. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y
Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Ünal S; Aktaş Y; Benito JM; Bilensoy E
Int J Pharm; 2020 Jun; 584():119468. PubMed ID: 32470483
[TBL] [Abstract][Full Text] [Related]
3. A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin.
Zhang YM; Cao Y; Yang Y; Chen JT; Liu Y
Chem Commun (Camb); 2014 Nov; 50(86):13066-9. PubMed ID: 25222700
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anticancer activity of drug nanoparticles formulated with β-cyclodextrin.
Zhan H; Jagtiani T; Liang JF
Anticancer Drugs; 2017 Mar; 28(3):271-280. PubMed ID: 27926611
[TBL] [Abstract][Full Text] [Related]
5. CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT.
Du F; Meng H; Xu K; Xu Y; Luo P; Luo Y; Lu W; Huang J; Liu S; Yu J
Colloids Surf B Biointerfaces; 2014 Jan; 113():230-6. PubMed ID: 24096159
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
[TBL] [Abstract][Full Text] [Related]
8. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
He W; Du Y; Zhou W; Wang T; Li M; Li X
Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
[TBL] [Abstract][Full Text] [Related]
9. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release.
Zhang YH; Zhang YM; Sheng X; Wang J; Liu Y
Chem Commun (Camb); 2020 Jan; 56(7):1042-1045. PubMed ID: 31868189
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
Xu Z; Zheng W; Yin Z
Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
[TBL] [Abstract][Full Text] [Related]
13. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
[TBL] [Abstract][Full Text] [Related]
14. Targeted polysaccharide nanoparticle for adamplatin prodrug delivery.
Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
J Med Chem; 2013 Dec; 56(23):9725-36. PubMed ID: 24252070
[TBL] [Abstract][Full Text] [Related]
15. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol.
Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
Sci Rep; 2016 Jan; 6():19212. PubMed ID: 26759029
[TBL] [Abstract][Full Text] [Related]
17. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
[TBL] [Abstract][Full Text] [Related]
18. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
[TBL] [Abstract][Full Text] [Related]
19. Hollow nanosphere fabricated from β-cyclodextrin-grafted α,β-poly(aspartic acid) as the carrier of camptothecin.
Zeng J; Huang H; Liu S; Xu H; Huang J; Yu J
Colloids Surf B Biointerfaces; 2013 May; 105():120-7. PubMed ID: 23376743
[TBL] [Abstract][Full Text] [Related]
20. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
